Proactive vaccination using multiviral Quartet Nanocages to elicit broad anti-coronavirus responses.
Journal article
Hills RA. et al, (2024), Nat Nanotechnol
Single-cycle influenza virus vaccine generates lung CD8+ Trm that cross-react against viral variants and subvert virus escape mutants.
Journal article
Zheng MZM. et al, (2023), Sci Adv, 9
The molecular reach of antibodies determines their SARS-CoV-2 neutralisation potency
Preprint
Huhn A. et al, (2023)
Broadly neutralizing aptamers to SARS-CoV-2: A diverse panel of modified DNA antiviral agents.
Journal article
Gelinas AD. et al, (2023), Mol Ther Nucleic Acids, 31, 370 - 382
Multiviral Quartet Nanocages Elicit Broad Anti-Coronavirus Responses for Proactive Vaccinology.
Journal article
Hills RA. et al, (2023), bioRxiv
Structural basis for a conserved neutralization epitope on the receptor-binding domain of SARS-CoV-2.
Journal article
Huang K-YA. et al, (2023), Nat Commun, 14
Recombinant single-cycle influenza virus with exchangeable pseudotypes allows repeated immunization to augment anti-tumour immunity with immune checkpoint inhibitors.
Journal article
Kandasamy M. et al, (2023), Elife, 12
Cutting Edge: High-Dose Live Attenuated Influenza Vaccines Elicit Pulmonary Tissue-Resident Memory CD8+ T Cells in the Face of Pre-Existing Humoral Immunity.
Journal article
Zheng MZM. et al, (2022), J Immunol, 209, 1832 - 1836
Cutting Edge: High-Dose Live Attenuated Influenza Vaccines Elicit Pulmonary Tissue-Resident Memory CD8+ T Cells in the Face of Pre-Existing Humoral Immunity.
Journal article
Zheng MZM. et al, (2022), J Immunol
Mosaic RBD nanoparticles protect against challenge by diverse sarbecoviruses in animal models.
Journal article
Cohen AA. et al, (2022), Science, 377
Pathogen-sugar interactions revealed by universal saturation transfer analysis.
Journal article
Buchanan CJ. et al, (2022), Science, 377
SpySwitch enables pH- or heat-responsive capture and release for plug-and-display nanoassembly.
Journal article
Vester SK. et al, (2022), Nat Commun, 13
Immune responses to Sinopharm/BBIBP-CorV in individuals in Sri Lanka.
Journal article
Jeewandara C. et al, (2022), Immunology
Kinetics of immune responses to SARS-CoV-2 proteins in individuals with varying severity of infection and following a single dose of the AZD1222.
Journal article
Jayathilaka D. et al, (2022), Clin Exp Immunol, 208, 323 - 331
Persistence of immune responses to the Sinopharm/BBIBP-CorV vaccine.
Journal article
Jeewandara C. et al, (2022), Immun Inflamm Dis, 10
Secondary influenza challenge triggers resident memory B cell migration and rapid relocation to boost antibody secretion at infected sites.
Journal article
MacLean AJ. et al, (2022), Immunity, 55, 718 - 733.e8
Kinetics of immune responses to the AZD1222/Covishield vaccine with varying dose intervals in Sri Lankan individuals.
Journal article
Jeewandara C. et al, (2022), Immun Inflamm Dis, 10
Mosaic RBD nanoparticles protect against multiple sarbecovirus challenges in animal models.
Journal article
Cohen AA. et al, (2022), bioRxiv
SARS-CoV-2 Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses.
Journal article
Dejnirattisai W. et al, (2022), Cell, 185, 467 - 484.e15